CCA
ORGO icon

Castle Creek Arbitrage’s Organogenesis Holdings ORGO Stock Holding History

Castle Creek Arbitrage’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-79,806
Closed -$796K – 79
2018
Q1 		$796K Buy
+79,806
New +$795K 0.06% 50

Other funds holding ORGO

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Castle Creek Arbitrage's ORGO Position: Q2 2018 in Review

Castle Creek Arbitrage sold out of Organogenesis Holdings (ORGO) in Q2 2018, closing a stake of 79,806 shares — an estimated $796K sold.

Castle Creek Arbitrage first reported a position in ORGO in Q1 2018 and held it in 1 quarter. The position peaked at $796K in Q1 2018. 34 funds tracked by Wall St. Rank hold ORGO as of Q2 2018.

  • Castle Creek Arbitrage reported no remaining Organogenesis Holdings position as of Q2 2018 after selling out during the quarter.
  • Castle Creek Arbitrage sold 79,806 Organogenesis Holdings shares in Q2 2018, an estimated $796K.
  • Castle Creek Arbitrage first reported a position in Organogenesis Holdings in Q1 2018 and held it in 1 quarter.
  • Castle Creek Arbitrage's Organogenesis Holdings position peaked at $796K in Q1 2018.
  • 34 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2018.

Based on Castle Creek Arbitrage's 13F filing for Q2 2018, filed 18 Jul 2018.